Invivoscribe

Invivoscribe company information, Employees & Contact Information

Explore related pages

Related company profiles:

Invivoscribe® is a global leader dedicated to Improving Lives with Precision Diagnostics®, advancing the quality of healthcare by providing innovative products and clinical services for oncology. Our Streamlined CDx® (companion diagnostic) model accelerates the development of novel therapeutics, enabling personalized approaches to patient care. With products manufactured in our state-of-the-art cGMP facility, we provide a comprehensive range of platform agnostic assays, reagents, controls and software for clonal gene rearrangements, translocations, gene mutation testing, and measurable residual disease (MRD). Invivoscribe’s products consistently surpass industry and regulatory standards and play a crucial role in identifying, stratifying and monitoring hematologic cancers, enabling scientific advancements and empowering clinicians to make informed treatment decisions. Our subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM®), offers extensive clinical diagnostic and biopharma services for the detection and monitoring of myelo- and lymphoproliferative disorders. The LabPMM network performs globally standardized flow cytometry and molecular testing services for pharmaceutical and healthcare organizations, providing results that are critically important for patient care in the U.S., Europe, and Asia. Join us in our mission to revolutionize oncology diagnostics and improve patient outcomes worldwide. Visit our website to discover how Invivoscribe’s ecosystem is driving advancements in precision medicine.

Company Details

Employees
197
Founded
-
Address
10222 Barnes Canyon Rd, Building 1,france
Phone
8582246601
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
San Diego, California
Looking for a particular Invivoscribe employee's phone or email?

Invivoscribe Questions

News

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial - Business Wire

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial Business Wire

Invivoscribe Renews U.S. Headquarters Lease in Sorrento Mesa - Connect CRE

Invivoscribe Renews U.S. Headquarters Lease in Sorrento Mesa Connect CRE

Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay - Business Wire

Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay Business Wire

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - PR Newswire

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine PR Newswire

Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials - Business Wire

Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials Business Wire

2025 UCLA Chemistry and Biochemistry Alumni Award - UCLA – Chemistry and Biochemistry

2025 UCLA Chemistry and Biochemistry Alumni Award UCLA – Chemistry and Biochemistry

FDA Approves Companion Diagnostic for Quizartinib in FLT3-ITD+ AML - OncLive

FDA Approves Companion Diagnostic for Quizartinib in FLT3-ITD+ AML OncLive

Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in China - PR Newswire

Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in China PR Newswire

Blood Cancer Diagnostics Market Analysis Report 2025-2030, - GlobeNewswire

Blood Cancer Diagnostics Market Analysis Report 2025-2030, GlobeNewswire

Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China - Via TT

Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China Via TT

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - PR Newswire

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML PR Newswire

Top Invivoscribe Employees

  • Eric Vennemeyer

    Eric Vennemeyer

    n/a

    Carlsbad, California, United States, United States
    5
    citeline.com, usa.com, appliedbiosystems.com, sartorius.de, omniome.com

    2 +165040XXXXX

  • Austin Jacobsen

    Austin Jacobsen

    n/a

    San Diego, California, United States, United States
    6
    biomatrica.com, yahoo.com, gmail.com, mindspring.com, ipa.net, invivoscribe.com

    4 +161931XXXXX

  • Steve Brown

    Steve Brown

    Network Security Engineer @…

    San Diego, California, United States, United States
    4
    gmail.com, closing.com, san.rr.com, dermtech.com

    8 +185841XXXXX

  • Zephyr Fors, MBA

    Zephyr Fors, MBA

    n/a

    San Diego, California, United States, United States
    3
    yahoo.com, invivoscribe.com, rokabio.com

    2 +190860XXXXX

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant